Saturday, May 16, 2020 9:47:15 AM
Down from 40,237,198 71.4% at 12-31-19 (assuming 2.6M Ronin shares sold – see below).
28,296,779 50.1% INSTITUTIONS (a/o 3-31-20)
https://www.nasdaq.com/symbol/cdmo/institutional-holdings
+ 8,585,992 15.2% LARGE SHAREHOLDERS via Forms13/14 (EasternCap/Dart, Tappan) – ie, not in Nasdaq Inst. List.
------------
= 36,882,771 65.3%
1. I’m not sure about Eastern Cap(K.Dart): no updates since 12-2017, assume NO CHG.
2. Also assuming that a/o 3-20-2020, Ronin(Stafford/Farley) has no ownership (they owned 2,638,450 4.7% a/o 4-17-18 13D https://tinyurl.com/ycf7d2uk ): 3-20-20 https://www.pionline.com/trading/ronin-capital-assets-auctioned (“CME Group auctioned off Ronin’s portfolios in March”. Maybe whoever bought Ronin’s portfolio still owns the 2,638,450 shares of CDMO? See RONIN NOTE AT BOTTOM. So strange.)
Note: Ownership %’s based on 56,482,154 common O/S at 3-2-20 (10Q: https://tinyurl.com/vkocrsg )
11 LARGEST SHAREHOLDERS:
1. IsZo Capital Mgt. (Brian Sheehy): 5,645,701 10.0% (+1,425,553 a/o 3-31-20 Nasdaq Inst.)
2. Eastern Capital (Kenneth Dart): 4,300,992 7.6% (a/o 12-7-17 14A: https://tinyurl.com/y7qprpg9 acq. 10-2015)
3. Tappan Street (Prasad Phatak): 4,285,000 7.6% (a/o 12-31-19 13G: https://tinyurl.com/wlcwnnv )
4. Blackrock Inc. (Larry Fink): 3,881,521 6.9% (-52,910 a/o 3-31-20 Nasdaq Inst.)
5. Vanguard Group 2,638,045 4.7% (+57,499 q/e 3-31-20 Nasdaq Inst.)
6. Snyder Capital 2,280,905 4.0% (+98,519 a/o 3-31-20 Nasdaq Inst.)
7. Altravue Capital 1,950,355 3.5% (-261,087 a/o 3-31-20 Nasdaq Inst.)
8. Sargent Invest. Grp. 1,165,997 2.1% (+204,415 a/o 3-31-20 Nasdaq Inst.)
9. State Street 1,038,673 1.8% (-21,871 a/o 3-31-20 Nasdaq Inst.)
10. Geode Capital 740,689 1.3% 42,493 (+42,493 a/o 3-31-20 Nasdaq Inst.)
11. Silvercrest Asset Mgt. 736,143 1.3% (+173,411 a/o 3-31-20 Nasdaq Inst.)
BIGGEST DROPS q/e 3-31-20:
Millennium -330,454 to 700,169
Two Sigma Investments -269,192 Sold Out
Oxford Asset Mgt. -264,077 Sold Out
Altravue Capital -261,087 to 1,950,355
= = = = = = = = = = = =
Shares O/S as of 3-2-20=56,482,154 - history since 4-2006: https://tinyurl.com/s9cmzmf
...A/O 1-31-20: 2,941,000 stock options outstanding at a wgt.avg. exercise price of $6.45 (pg.15 10Q).
3-10-20: Qtly. Conf. Call (Hancock/Hart/Compton) PR & Transcript https://tinyurl.com/s9cmzmf
4-30-20: “Ronin’s Collapse: The Mysterious Disappearance of a Chicago Trading Giant - Puzzling Losses, a Closely Guarded Auction and Possible Redemption”
By Costas Mourselas @CostasMourselas
More than a month after Ronin Capital’s portfolios were seized and sold off by clearing houses, much about the affair remains unknown, including the source of the firm’s losses and the results of the auction at CME. It’s not just observers that are in the dark. Risk.net understands Ronin’s management team is still waiting to find out what happened in the auction – information that could ultimately help determine whether the famed Chicago prop trader has some kind of future.
https://www.risk.net/risk-management/7535981/the-mysterious-disappearance-of-a-chicago-trading-giant
Recent CDMO News
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:33:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:32:11 AM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM